Sandbox:Nasrin: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
Line 18: | Line 20: | ||
|F03=Death}} | |F03=Death}} | ||
{{familytree/end}} | {{familytree/end}} | ||
{| class="wikitable" | |||
! colspan=4 style="background: #4479BA; color: #FFFFFF; " align="center"|CT manifestations of COVID-19 | |||
|- | |||
!style="background: #4479BA; color: #FFFFFF; " align="center" |CT findings | |||
!style="background: #4479BA; color: #FFFFFF; " align="center" |Definition | |||
!style="background: #4479BA; color: #FFFFFF; " align="center" |CT picture | |||
|- | |||
|style="background: #DCDCDC; |'''[[Ground glass opacity]]''' | |||
| | |||
*Hazy opacity in the lungs with well defined bronchial and vascular margins | |||
*the most common imaging finding | |||
*due to infection, chronic interstitial lung disease, and acute lung injury | |||
|[[File:Covid-19-pneumonia-26.jpg|200px|thumb|center]] | |||
|- | |||
|style="background: #DCDCDC; |'''[[Consolidation]]''' | |||
| | |||
*a parenchymal density with ill-defined bronchial and vascular margins | |||
*filling with infectious material [fluid, cells, tissue] | |||
* due to cellular exudates in alveoli | |||
|[[file | |||
|- | |||
|style="background: #DCDCDC; |''' [[Crazy paving pattern]] ''' | |||
| | |||
* Septal thickening of inter and intra-lobar regions | |||
* with the background of the Ground glass opacity | |||
* Similar to paving stones | |||
* Due to alveolar edema and acute inflammation of the lung | |||
* Sign of progression | |||
|[[File:Covid-19-pneumonia-122.jpg|200px|thumb|center]] | |||
|- | |||
|style="background: #DCDCDC; |''' [[Reticuldar]] pattern ''' | |||
| | |||
*Linear opacities in the lungs | |||
*Due to Interstitial thickening of inter and intralobular septa | |||
|[[file | |||
|- | |||
|style="background: #DCDCDC; |'''[[Air bronchogram]] ''' | |||
| | |||
* Air-filled bronchi | |||
*Low attenuated areas in the lung | |||
|[[file | |||
|- | |||
|style="background: #DCDCDC; |''' [[Bronchiectasis]] ''' | |||
| | |||
*irreversible dilatation of the lung airways | |||
* Bronchus diameter more than 1.5 cm | |||
*due to inflammation, obstruction and impaired clearance | |||
|[[file | |||
|} |
Latest revision as of 13:33, 15 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
COVID-19 | |||||||||||||||||||||||||||||||||||||||||||||||
30-40% Asymptomatic | 60-70% Symptomatic | ||||||||||||||||||||||||||||||||||||||||||||||
Asymptomatic carrier | 80% Mild symtoms | 14% Severe symptoms | 6% Critically ill | ||||||||||||||||||||||||||||||||||||||||||||
Fever Chills Cough Headache Sore throat Nasal congestion or secretion Fatigue Body aches loss of taste or smell Nausea or vomiting Diarrhea | Severe Dyspnea Chest pain Severe weakness new Confusion Central Cyanosis | Death | |||||||||||||||||||||||||||||||||||||||||||||
CT manifestations of COVID-19 | |||
---|---|---|---|
CT findings | Definition | CT picture | |
Ground glass opacity |
|
||
Consolidation |
|
[[file | |
Crazy paving pattern |
|
| |
Reticuldar pattern |
|
[[file | |
Air bronchogram |
|
[[file | |
Bronchiectasis |
|
[[file |